Lyell Immunopharma, Inc. (LYEL)
23.33
-0.77
(-3.20%)
USD |
NASDAQ |
Mar 03, 16:00
23.32
-0.01
(-0.04%)
After-Hours: 20:00
Lyell Immunopharma Market Cap : 345.47M for March 3, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Insmed, Inc. | 31.69B |
| Nektar Therapeutics | 1.178B |
| GT Biopharma, Inc. | 12.52M |
| Regeneron Pharmaceuticals, Inc. | 81.05B |
| Vertex Pharmaceuticals, Inc. | 120.48B |
Market Cap Related Metrics
| PS Ratio | 84599.36 |
| PEG Ratio | -0.0005 |
| Price to Book Value | 1.050 |
| Price | 23.33 |
| Earnings Yield | -83.97% |
| PEGY Ratio | -0.0005 |